"Big Pharma involvement in IL-12 is fading fast. Days after Bristol Myers Squibb punted its IL-12 fusion protein, AstraZeneca has jettisoned a gene therapy to dial down its interest in the cytokine for the second time in as many quarters."

https://www.fiercebiotech.com/biotech/astrazeneca-deals-another-blow-il-12-dumping-gene-therapy-follow-bristol-myers-merck-kgaa